Ching Kit Chan
Papers
1
Total Citations
11
H-Index
1
About
Dr. Ching Kit Chan is a trailblazer in the field of bioanalytical instrumentation and antibody discovery, with a core focus on advancing high-throughput screening technologies. His most-cited work, "Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development" (2018, 11 citations), tackles a critical bottleneck in therapeutic antibody development: the labor-intensive sample preparation that traditionally restricts flow cytometry’s utility as a primary screening tool. By engineering an automated, high-content platform, Dr. Chan demonstrated how to merge the sensitivity of flow cytometry with the scalability needed for modern drug discovery, enabling rapid, accurate identification of lead antibody candidates. This innovation directly addresses the pharmaceutical industry’s growing demand for efficient, high-fidelity screening methods in the era of biologic therapeutics. Though his citation count reflects a focused, emerging impact, his work stands out for its practical, problem-solving approach—streamlining a gold-standard technique to meet industrial throughput requirements. For students and researchers in bioengineering and drug development, Dr. Chan’s contributions exemplify how thoughtful automation can transform a laboratory staple into a powerful engine for translational discovery.
Research Focus
Key Achievements
Top Papers
- 1